Global spinal biologics market to exceed $2.36B by 2021: 3 findings

The global spinal biologics market is predicted to grow at a 3.75 percent compound annual growth rate, reaching $2.36 billion by 2021, according to a Research Cosmos report.

Advertisement

Here are three findings:

1. In 2013, the market was valued at $1.8 billion.

2. North America dominates the global spinal biologics market, with the U.S. leading the pack.

3. Key companies in the market include DePuy Synthes, NuVasive and Orthofix International.

More articles on biologics:
Anika Therapeutics resumes distribution of cartilage regeneration treatments
AlloSource earns laser etching patent: 3 notes
4 things to know about Bio2 Technologies

Advertisement

Next Up in Biologics

Advertisement

Comments are closed.